Eva Hoster
Impact in
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Lymphoma Diagnosis and Treatment 132
- Hematology 15
- Acute Myeloid Leukemia Research 14
- Co-authors
- Wolfgang Hiddemann (70 shared papers)Martin H. Dreyling (75 shared papers)Michael Unterhalt (62 shared papers)Bernhard Josef Wormann (16 shared papers)Bernd Metzner (17 shared papers)Joerg Hasford (7 shared papers)Hannes Wandt (9 shared papers)Michael G. Pfreundschuh (12 shared papers)
- Journals
- Blood (57 papers)Journal of Clinical Oncology (14 papers)Leukemia (12 papers)Hematological Oncology (11 papers)Blood Advances (9 papers)
- Partner nations
- GermanyFranceNetherlands
In The Last Decade
Eva Hoster
171 papers receiving 9.1k citations
Eva Hoster's Hit Papers
Peers
Comparison fields: 5 of 115
- Pathology and Forensic Medicine 6.2k
- Hematology 1.1k
- Oncology 870
- Genetics 256
- Cancer Research 185
Countries citing papers authored by Eva Hoster
This map shows the geographic impact of Eva Hoster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hoster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hoster more than expected).
Fields of papers citing papers by Eva Hoster
This network shows the impact of papers produced by Eva Hoster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hoster. The network helps show where Eva Hoster may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Hoster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Hit paper breakdown → | 2007 | 767 |
| 2 | Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Hit paper breakdown → | 2015 | 512 |
| 3 | 2005 | 470 | |
| 4 | Treatment of Older Patients with Mantle-Cell Lymphoma Hit paper breakdown → | 2012 | 403 |
| 5 | CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma Hit paper breakdown → | 2021 | 370 |
| 6 | 2008 | 341 | |
| 7 | Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network Hit paper breakdown → | 2016 | 315 |
| 8 | Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network Hit paper breakdown → | 2016 | 279 |
| 9 | 2009 | 245 | |
| 10 | 2009 | 224 | |
| 11 | 2019 | 200 | |
| 12 | 2007 | 190 | |
| 13 | 2006 | 180 | |
| 14 | 2007 | 171 | |
| 15 | 2022 | 156 | |
| 16 | 2009 | 140 | |
| 17 | 2015 | 140 | |
| 18 | Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials Hit paper breakdown → | 2022 | 138 |
| 19 | 2014 | 133 | |
| 20 | 2017 | 130 |
About Eva Hoster
Eva Hoster is a scholar working on Pathology and Forensic Medicine, Hematology, Endocrinology, Diabetes and Metabolism, Oncology and Rehabilitation, having authored 179 papers that have together received 9.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (132 papers), Acute Myeloid Leukemia Research (14 papers), CAR-T cell therapy research (7 papers), Exercise and Physiological Responses (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Hearing Loss and Rehabilitation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.2k citations), Hematology (1.1k citations), Oncology (870 citations), Genetics (256 citations) and Cancer Research (185 citations). Eva Hoster has collaborated with scholars based in Germany, France and Netherlands. Frequent co-authors include Wolfgang Hiddemann, Martin H. Dreyling, Michael Unterhalt, Bernhard Josef Wormann, Bernd Metzner, Joerg Hasford, Hannes Wandt, Michael G. Pfreundschuh, Hartmut Eimermacher and Marcel Reiser. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Hematological Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.